Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1975 6
1976 3
1977 5
1978 6
1979 14
1980 22
1981 20
1982 18
1983 10
1984 19
1985 11
1986 9
1987 7
1988 5
1989 4
1990 8
1991 9
1992 8
1993 3
1994 5
1995 11
1996 8
1997 14
1998 19
1999 14
2000 27
2001 30
2002 38
2003 35
2004 32
2005 54
2006 62
2007 65
2008 87
2009 68
2010 90
2011 91
2012 91
2013 113
2014 114
2015 99
2016 146
2017 138
2018 157
2019 187
2020 118
Text availability
Article attribute
Article type
Publication date

Search Results

1,889 results
Results by year
Filters applied: . Clear all
Page 1
Cannabinoid Signaling in Cancer.
Das S, Kaul K, Mishra S, Charan M, Ganju RK. Das S, et al. Adv Exp Med Biol. 2019;1162:51-61. doi: 10.1007/978-3-030-21737-2_4. Adv Exp Med Biol. 2019. PMID: 31332734 Review.
The family of chemical structures that interact with a cannabinoid receptor are broadly termed cannabinoids. Traditionally known for their psychotropic effects and their use as palliative medicine in cancer, cannabinoids are very versatile and are know …
The family of chemical structures that interact with a cannabinoid receptor are broadly termed cannabinoids. Traditionally kno …
Cannabis in cancer care.
Abrams DI, Guzman M. Abrams DI, et al. Clin Pharmacol Ther. 2015 Jun;97(6):575-86. doi: 10.1002/cpt.108. Epub 2015 Apr 17. Clin Pharmacol Ther. 2015. PMID: 25777363 Free article. Review.
Cannabinoids, the active components of Cannabis sativa, mimic the effects of the endogenous cannabinoids (endocannabinoids), activating specific cannabinoid receptors, particularly CB1 found predominantly in the central nervous system and CB2 found predominan
Cannabinoids, the active components of Cannabis sativa, mimic the effects of the endogenous cannabinoids (endocannabinoids), a
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence.
Davis MP. Davis MP. J Natl Compr Canc Netw. 2016 Jul;14(7):915-22. doi: 10.6004/jnccn.2016.0094. J Natl Compr Canc Netw. 2016. PMID: 27407130 Review.
Cannabinoids are known to modulate a multitude of monoamine receptors. Structurally, there are 3 groups of cannabinoids. Multiple studies, most of which are of moderate to low quality, demonstrate that tetrahydrocannabinol (THC) and oromucosal cannabinoid com
Cannabinoids are known to modulate a multitude of monoamine receptors. Structurally, there are 3 groups of cannabinoids. Multi
Future Aspects for Cannabinoids in Breast Cancer Therapy.
Kisková T, Mungenast F, Suváková M, Jäger W, Thalhammer T. Kisková T, et al. Int J Mol Sci. 2019 Apr 3;20(7):1673. doi: 10.3390/ijms20071673. Int J Mol Sci. 2019. PMID: 30987191 Free PMC article. Review.
Cannabinoids (CBs) from Cannabis sativa provide relief for tumor-associated symptoms (including nausea, anorexia, and neuropathic pain) in the palliative treatment of cancer patients. ...They reduce angiogenesis and tumor metastasis in animal breast cancer mo
Cannabinoids (CBs) from Cannabis sativa provide relief for tumor-associated symptoms (including nausea, anorexia, and neuropathic pai
Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer.
Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L. Pellati F, et al. Biomed Res Int. 2018 Dec 4;2018:1691428. doi: 10.1155/2018/1691428. eCollection 2018. Biomed Res Int. 2018. PMID: 30627539 Free PMC article. Review.
The National Cancer Institute (NCI) currently recognizes medicinal C. sativa as an effective treatment for providing relief in a number of symptoms associated with cancer, including pain, loss of appetite, nausea and vomiting, and anxiety. ...In the light of all the …
The National Cancer Institute (NCI) currently recognizes medicinal C. sativa as an effective treatment for providing relief in a numb …
Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R, Ambwani SR, Singh S. Kaur R, et al. Curr Clin Pharmacol. 2016;11(2):110-7. doi: 10.2174/1574884711666160418105339. Curr Clin Pharmacol. 2016. PMID: 27086601 Review.
Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, cancer, obesity, metabolic syndrome related diseases, Parkinson's disease, Huntington's disease, Alzheimer's di …
Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, …
Medical marijuana for cancer.
Kramer JL. Kramer JL. CA Cancer J Clin. 2015 Mar;65(2):109-22. doi: 10.3322/caac.21260. Epub 2014 Dec 10. CA Cancer J Clin. 2015. PMID: 25503438 Free article. Review.
Investigations into these medicinal properties has led to the development of cannabinoid pharmaceuticals such as dronabinol, nabilone, and nabiximols. ...Nabilone has been best studied for the treatment of nausea secondary to cancer chemotherapy. There are also limi …
Investigations into these medicinal properties has led to the development of cannabinoid pharmaceuticals such as dronabinol, nabilone …
Medical Use of Cannabinoids.
Fraguas-Sánchez AI, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Drugs. 2018 Nov;78(16):1665-1703. doi: 10.1007/s40265-018-0996-1. Drugs. 2018. PMID: 30374797 Review.
As a result, it has been reported that changes in endocannabinoid levels may be related to neurological diseases such as Parkinson's disease, Huntington's disease, Alzheimer's disease and multiple sclerosis, as well as anorexia and irritable bowel syndrome. . …
As a result, it has been reported that changes in endocannabinoid levels may be related to neurological diseases such as Parkinson's
Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
Lötsch J, Weyer-Menkhoff I, Tegeder I. Lötsch J, et al. Eur J Pain. 2018 Mar;22(3):471-484. doi: 10.1002/ejp.1148. Epub 2017 Nov 21. Eur J Pain. 2018. PMID: 29160600 Review.
Cannabinoid CB(1) receptors are widely expressed throughout the nociceptive system. Their activation by endogenous or exogenous cannabinoids modulates the release of neurotransmitters. This is reflected in antinociceptive effects of cannabinoids in preclinica
Cannabinoid CB(1) receptors are widely expressed throughout the nociceptive system. Their activation by endogenous or exogenous ca
Cannabis for cancer - illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology.
Turgeman I, Bar-Sela G. Turgeman I, et al. Expert Opin Investig Drugs. 2019 Mar;28(3):285-296. doi: 10.1080/13543784.2019.1561859. Epub 2018 Dec 29. Expert Opin Investig Drugs. 2019. PMID: 30572744 Review.
AREAS COVERED: The use of Cannabis and cannabinoid-based-medicines in oncology is summarized in this article. Cannabinoids are classified according to natural and synthetic subtypes and their mechanisms of action expounded. The variability of available products is d …
AREAS COVERED: The use of Cannabis and cannabinoid-based-medicines in oncology is summarized in this article. Cannabinoids are …
1,889 results
Jump to page
Feedback